Recurrence-free and overall survival among elderly stage III colon cancer patients treated with CAPOX or capecitabine monotherapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Recurrence-free and overall survival among elderly stage III colon cancer patients treated with CAPOX or capecitabine monotherapy

Published:2016-09-22 Issue:1 Volume:140 Page:224-233
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

van Erning F.N.¹²,Janssen-Heijnen M.L.G.³⁴,Creemers G.J.⁵,Pruijt J.F.M.⁶,Maas H.A.A.M.⁷,Lemmens V.E.P.P.¹²

Affiliation:

1. Department of Research; Netherlands Comprehensive Cancer Organisation; Eindhoven The Netherlands

2. Department of Public Health; Erasmus MC; Rotterdam The Netherlands

3. Department of Clinical Epidemiology; VieCuri Medical Centre; Venlo The Netherlands

4. Department of Epidemiology; Maastricht UMC, GROW School for Oncology and Developmental Biology; Maastricht The Netherlands

5. Department of Internal Medicine; Catharina Hospital; Eindhoven The Netherlands

6. Department of Internal Medicine; Jeroen Bosch Hospital, 's-Hertogenbosch; The Netherlands

7. Department of Geriatric Medicine; Elisabeth-TweeSteden Hospital; Tilburg The Netherlands

Funder

The Netherlands Organisation for Health Research and Development

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference29 articles.

1. Capecitabine as adjuvant treatment for stage III colon cancer;Twelves;N Engl J Med,2005

2. Oral capecitabine as an alternative to i.v. 5-fluorouracil-based adjuvant therapy for colon cancer: safety results of a randomized, phase III trial;Scheithauer;Ann Oncol,2003

3. Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial;Andre;J Clin Oncol,2009

4. Oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: results from NSABP C-07;Kuebler;J Clin Oncol,2007

5. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer;Andre;N Engl J Med,2004

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Estimating Treatment Effect of Adjuvant Chemotherapy in Elderly Patients With Stage III Colon Cancer Using Bayesian Networks;JCO Clinical Cancer Informatics;2023-09

2. Incidence of Disease Recurrence in Patients With Colon and Upper Rectum Adenocarcinoma Stage II and III Receiving Adjuvant Capecitabine Monotherapy: Do Number of Chemotherapy Cycles and Relative Dose Intensity of the Drug Play a Role?;Clinical Colorectal Cancer;2023-06

3. Does adjuvant chemotherapy improve outcomes in elderly patients with colorectal cancer? A systematic review and meta-analysis of real-world studies;Expert Review of Gastroenterology & Hepatology;2022-03-31

4. New diagnostic measures of oxaliplatin-induced peripheral sensory neuropathy;Cancer Treatment and Research Communications;2022

5. Suboptimal Completion Rates, Adverse Events, Costs, Resource Utilization, and Cost Impact of Noncompletion in Oral Adjuvant Capecitabine–Based Chemotherapy in Patients With Early-Stage Colon Cancer;Clinical Colorectal Cancer;2021-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3